Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 10Colorectal Neoplasms 8Rectal Neoplasms 4Neoplasm Metastasis 3Pancreatic Neoplasms 2Lung Neoplasms 2Immunotherapy 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Mid-low Rectal Cancer 1Locally Advanced Rectal Cancer With Liver Metastases 1Locally Advanced Rectal Cancer 1Liver Metastases of Colorectal Cancer 1Immunotherapy Gastrict Cancer 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Cancer Liver Metastasis 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Adenocarcinoma 1

Interventions

sintilimab 1Oxaliplatin 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Colorectal Cancer Liver Metastasis × Oxaliplatin × Clear all
NCT06788171 2025-01-23

PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM

Fujian Cancer Hospital

Phase 2 Not yet recruiting
35 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡